Hints and tips:
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...“I’d put Vertex in my pharma top three [to invest in].” This year, Vertex’s market capitalisation surpassed $100bn for the first time....
Company would have been better off following Roche’s route to market for anti-obesity treatment
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...US President Joe Biden has put his fight against Big Pharma at the centre of his re-election campaign, championing his efforts to lower drug prices through the Inflation Reduction Act....
...Its — untested — argument is that Amgen could use rebates on its blockbusters to encourage insurers and pharmacy benefit managers to favour Horizon’s drugs....
...“Investors previously focused on Tesla’s EV volume and cost advantage will potentially throw in the towel and eventually be replaced by AI/tech investors with longer time horizons.”...
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...Big Pharma has always bought out small drug developers to restock its pipelines. Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...Could a tsunami of private equity debt restructurings be on the horizon as public equities approach fresh highs? Who Cares? Does it really matter if cogs in the billionaire factory are a bit jammed?...
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...Amgen and Horizon indicated they would try to complete the deal by fighting the FTC in court....
...Just a comms guy with an eye on the horizon. Maybe a near term realist. This is going to change everything and people like me need to stay on top of it. But my focus is on what’s possible now....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...Horizon Pharmaceuticals was down more than 17 per cent before the opening bell after Bloomberg reported late on Monday that the Federal Trade Commission was expected to block Amgen’s $28.3bn acquisition...
...It was something tenable on the horizon, so was a reason to look past the current EV sales slump....
...The FTC attempted to block Amgen’s $28.3bn takeover of Horizon Therapeutics. Barriers to M&A are going to make it harder for pharma companies to replenish drug pipelines....
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
...In Amgen’s case, the FTC argued that the Big Pharma group could get buyers to favour Horizon’s drugs by bundling them with its own best medicines....
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...Plenty of people raised questions about BP’s corporate governance in the wake of the disastrous Deepwater Horizon oil spill in 2010....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Last month the Federal Trade Commission caused shockwaves when it sued to block Amgen’s takeover of Horizon Therapeutics — a $28bn deal announced in December that kick-started the nascent M&A recovery....
International Edition